A novel conditioning-free hematopoietic stem cell transplantation model in zebrafish

被引:5
|
作者
Fraint, Ellen [1 ]
Norberto, Maria Feliz [2 ]
Bowman, Teresa, V [3 ,4 ,5 ]
机构
[1] Childrens Hosp Montefiore, Dept Pediat Hematol Oncol, Bronx, NY USA
[2] Albert Einstein Coll Med, Natl Inst Hlth Postbaccalaureate Res Educ Program, Bronx, NY 10467 USA
[3] Albert Einstein Coll Med, Gottesman Inst Stem Cell Biol & Regenerat Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Med Oncol, Bronx, NY 10467 USA
[5] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA
基金
美国国家卫生研究院;
关键词
ENGRAFTMENT;
D O I
10.1182/bloodadvances.2020002424
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Transplantation is the most common assay for measuring the in vivo functionality of hematopoietic stem cells (HSCs). Although various HSC transplantation strategies have been developed in zebrafish, they are underutilized because of challenges related to immune matching and preconditioning toxicity. To circumvent these limitations, we developed a simple and robust transplantation model using HSC-deficient hosts. Homozygous runx1(W84X) mutants are devoid of definitive hematopoietic cells, including HSCs and adaptive immune cells; thus, they require no preconditioning regimen for transplantation. Marrow cell transplantation into runx1-mutant zebrafish 2 days after fertilization significantly improved their survival to adulthood and resulted in robust, multilineage, long-lasting, serially repopulating engraftment. Furthermore, we demonstrated that engraftment into runx1 homozygous mutants was significantly higher than into runx1 heterozygotes, demonstrating that the improved transplantation success is attributable to the empty HSC niche in mutants and not just the embryonic environment. Competitive transplantation of marrow cells into runx1 mutants revealed a stem cell frequency similar to that of murine marrow cells, which demonstrates the utility of this model for quantifying HSC function. The streamlined approach and robustness of this assay will help broaden its feasibility for future high-throughput transplantation experiments in zebrafish and will enable further novel discoveries in the biology of HSCs.
引用
收藏
页码:6189 / 6198
页数:10
相关论文
共 50 条
  • [21] Superior long term progression free survival of myeloablative allogeneic hematopoietic stem cell transplantation for multiple myeloma compared to autologous hematopoietic stem cell transplantation after identical conditioning regimen
    Khaled, Yaser
    Kato, Koji
    Levine, John E.
    Mellacheruvu, Smitha
    Jakubowiak, Andrzej
    Krijanovski, Oleg
    Peres, Edward
    Reddy, Pavan
    Knott, Kevin
    Yanik, Greg
    Ferrara, James
    Mineishi, Shin
    BLOOD, 2007, 110 (11) : 890A - 890A
  • [22] Treosulfan-based conditioning regimen in hematopoietic stem cell transplantation in children and adolescents: An analysis of spanish group of hematopoietic stem cell transplantation (GETH)
    Perez-Martinez, A.
    Belendez Bieler, C.
    Molina Angulo, B.
    Fuentes, C.
    Regueiro Garcia, A.
    Plaza Fornieles, M.
    Margarit Soler, A.
    Benitez Carabante, M. I.
    Olivas Mazon, R.
    Palomo Moraleda, P.
    Pascual Martinez, A.
    Sissini, L.
    Mozo del Castillo, Y.
    Bueno Sanchez, D.
    Galera Minarro, A. M.
    Alonso Garcia, L.
    Marsal, J.
    Trabazo del Castillo, M.
    Urtasun Erburu, A.
    Rifon, J.
    Palacios, M. L.
    Diaz, M. A.
    Diaz de Heredia, C.
    Fuster Soler, J. L.
    Fernandez Navarro, J. M.
    Gonzalez Vicent, M.
    Palacios, M. L.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 372 - 372
  • [23] A mouse model of in utero hematopoietic stem cell transplantation
    Wacharaprechanont, T
    Firpo, MT
    Goldberg, JD
    Pedersen, RA
    DEVELOPMENTAL BIOLOGY, 1998, 198 (01) : 196 - 196
  • [24] Treosulfan, Fludarabine and Cytarabine As Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation
    Hilgendorf, Inken
    Winkelmann, Nils
    Frietsch, Jochen J.
    Hunstig, Friederike
    Schnetzke, Ulf
    Scholl, Sebastian
    Hochhaus, Andreas
    Casper, Jochen
    BLOOD, 2018, 132
  • [25] Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning
    Servais, Sophie
    Baron, Frederic
    Beguin, Yves
    TRANSFUSION AND APHERESIS SCIENCE, 2011, 44 (02) : 205 - 210
  • [26] LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma
    Kelli Borges dos Santos
    Luciano José Megale Costa
    Gustavo Bettarello
    Marcus da Matta Abreu
    Graziela Toledo Costa Mayrink
    Mariza Aparecida Mota
    Luiz Cláudio Ribeiro
    Juliana Pereira
    Abrahão Elias Hallack Neto
    Bone Marrow Transplantation, 2019, 54 : 625 - 628
  • [27] High-dose treosulfan in conditioning prior to hematopoietic stem cell transplantation
    Glowka, Franciszek K.
    Romanski, Michal
    Wachowiak, Jacek
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (10) : 1275 - 1295
  • [28] Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen
    Frère, P
    Baron, F
    Bonnet, C
    Hafraoui, K
    Pereira, M
    Willems, E
    Fillet, G
    Beguin, Y
    BONE MARROW TRANSPLANTATION, 2006, 37 (04) : 411 - 418
  • [29] Effects of conditioning intensity on growth after hematopoietic stem cell transplantation in children
    Uemura, S.
    Hasegawa, D.
    Kozaki, A.
    Nino, N.
    Yokoi, T.
    Takafuji, S.
    Saito, A.
    Ishida, T.
    Kawasaki, K.
    Kosaka, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S467 - S467
  • [30] Extramedullary leukemic relapses following hematopoietic stem cell transplantation with nonmyeloablative conditioning
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    Vela-Ojeda, J
    Morales-Toquero, A
    David-Gómez-Rangel, J
    García-Ruiz-Esparza, MA
    López-Martínez, B
    Cantú-Rodríguez, OG
    Gutiérrez-Aguirre, CH
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 262 - 265